State Street Corp Allakos Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Allakos Inc. stock. As of the latest transaction made, State Street Corp holds 247,575 shares of ALLK stock, worth $311,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
247,575
Previous 247,975 0.16%
Holding current value
$311,944
Previous $247,000 35.22%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.54 - $0.92 $216 - $368
-400 Reduced 0.16%
247,575 $160,000
Q2 2024

Aug 14, 2024
SELL
$1.0 - $1.45 $1.16 Million - $1.68 Million
-1,157,212 Reduced 82.35%
247,975 $247,000
Q1 2024

May 15, 2024
BUY
$1.02 - $3.23 $22,240 - $70,426
21,804 Added 1.58%
1,405,187 $1.77 Million
Q4 2023

Feb 14, 2024
SELL
$1.72 - $3.18 $127,061 - $234,916
-73,873 Reduced 5.07%
1,383,383 $3.78 Million
Q3 2023

Nov 14, 2023
SELL
$2.13 - $5.55 $6.22 Million - $16.2 Million
-2,918,262 Reduced 66.7%
1,457,256 $3.31 Million
Q2 2023

Aug 14, 2023
BUY
$3.6 - $5.25 $1.97 Million - $2.88 Million
548,316 Added 14.33%
4,375,518 $19.1 Million
Q1 2023

May 15, 2023
BUY
$4.3 - $8.27 $1.52 Million - $2.92 Million
353,451 Added 10.17%
3,827,202 $17 Million
Q4 2022

Feb 14, 2023
BUY
$5.66 - $8.42 $18.5 Million - $27.6 Million
3,274,476 Added 1643.19%
3,473,751 $29.2 Million
Q3 2022

Nov 15, 2022
BUY
$3.02 - $6.12 $226,264 - $458,522
74,922 Added 60.25%
199,275 $1.22 Million
Q2 2022

Aug 15, 2022
SELL
$2.6 - $6.14 $1.71 Million - $4.05 Million
-659,200 Reduced 84.13%
124,353 $389,000
Q1 2022

May 16, 2022
SELL
$5.08 - $9.81 $3.3 Million - $6.38 Million
-649,978 Reduced 45.34%
783,553 $4.47 Million
Q4 2021

Feb 14, 2022
BUY
$8.55 - $111.89 $2.2 Million - $28.8 Million
257,014 Added 21.85%
1,433,531 $14 Million
Q3 2021

Nov 15, 2021
BUY
$76.53 - $110.43 $4.49 Million - $6.48 Million
58,646 Added 5.25%
1,176,517 $125 Million
Q2 2021

Aug 16, 2021
BUY
$85.37 - $114.1 $19.2 Million - $25.7 Million
225,146 Added 25.22%
1,117,871 $95.4 Million
Q1 2021

May 17, 2021
SELL
$109.73 - $153.66 $3.13 Million - $4.39 Million
-28,565 Reduced 3.1%
892,725 $102 Million
Q4 2020

Feb 16, 2021
SELL
$79.58 - $152.45 $5.33 Million - $10.2 Million
-66,993 Reduced 6.78%
921,290 $129 Million
Q3 2020

Nov 10, 2020
SELL
$66.43 - $90.99 $12.9 Million - $17.7 Million
-194,513 Reduced 16.45%
988,283 $80.5 Million
Q2 2020

Aug 14, 2020
BUY
$44.04 - $80.69 $16.4 Million - $30.1 Million
372,643 Added 46.0%
1,182,796 $85 Million
Q1 2020

May 11, 2020
BUY
$44.49 - $93.39 $36 Million - $75.7 Million
810,153 New
810,153 $36 Million

Others Institutions Holding ALLK

# of Institutions
81
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $107M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email